
Objective Veterans Health Administration Clinical Resource Hubs are regional telehealth hubs that provide Veterans access needed to geriatric mental health (GMH) services without long drive times to urban centers to find specialists. This analysis characterized the GMH telehealth services to examine differences between rural and non‐rural Veterans. Methods Electronic health record data were extracted (October 2021 to September 2023) for encounters delivered by telehealth GMH teams staffed by geriatric psychiatrists, pharmacists, geropsychologists, and neuropsychologists. Variables included Veteran demographics, diagnoses, severity of care needs, services delivered and visit modality. Descriptive statistics, chi‐square and t ‐tests summarized the data and examined rural and non‐rural differences. Results GMH clinicians completed 9282 encounters with 2013 Veterans (Mean age = 75.8). Most services were video to home (48.2%) followed by video to clinic (25.4%), and phone (22%) with no differences in service delivery modality among rural and non‐rural Veterans. Rural Veterans had a higher proportion of psychotherapy and dementia‐related services, and lower proportions of medication management and services for depression, anxiety, and serious mental illness compared with non‐rural Veterans. Conclusions Older Veterans access virtual GMH care for a wide range of mental health and cognitive disorders. The apparent higher utilization of psychotherapy and dementia services for rural compared with non‐rural Veterans may relate to barriers to obtaining these services locally, although it may be partially explained by variations in virtual team compositions and settings served. Relevance to Clinical Practice This evaluation suggests high acceptability of video‐delivered care for older, rural Veterans with high care needs.
Background:Patients with schizophrenia experience gaps in the human immunodeficiency virus (HIV) care continuum. We examined the impact of dual enrollment in Medicare upon HIV testing and retention among Medicaid-enrolled patients with schizophrenia. Methods:Using Medicaid Analytic eXtract and Medicare files from 2008 to 2012, we examined adult participants with schizophrenia enrolled in Medicaid or dually enrolled in Medicare and Medicaid. Our outcomes were (a) HIV testing probability among participants without HIV and (b) retention in HIV care among people living with HIV (PLWH) (two HIV viral loads or CD4+ counts >90 days apart and within 1 year). Results:The average annual HIV testing probability was 4.9% among dually enrolled and 7.4% among Medicaid-enrolled patients (p < 0.001). Compared to Medicaid-only, HIV testing for dually enrolled patients were highest among those with opioid use disorder or sexually transmitted infection (STI); and lowest among study sample aged 50-59 years, Asian or White race. Among PLWH, the average retention probability in care was 54.7% for dually enrolled and 44.7% for Medicaid-enrolled patients (p < 0.001). Compared to Medicaid-only, retention probability for dually enrolled patients were highest among those with an STI or dyslipidemia, and lowest among younger sample. Conclusions and Relevance:Dual Medicare enrollment for Medicaid-enrolled patients benefitted HIV retention efforts more than HIV testing efforts. Differences in public insurance coverage between HIV care retention and testing among patients with schizophrenia, emphasizes the need for ongoing evaluation of the HIV care continuum as payor coverage and policies continue to evolve.
Objective:This review examined the historical development of artificial intelligence (AI) in psychiatry from 1972 to 2025 and identified persistent barriers to clinical translation. Method:The review used a structured source-identification approach across PubMed/MEDLINE, Web of Science, Google Scholar, ScienceDirect, citation tracking, and targeted historical searches. It synthesized sources qualitatively and organized them chronologically. A structured evidence table summarized representative milestones by era, AI paradigm, clinical task, data modality, validation approach, implementation status, and translational limitation. Results:Psychiatric AI evolved from symbolic simulation and rule-based expert systems to connectionist models, supervised machine learning, computational psychiatry, digital phenotyping, multimodal monitoring, digital mental health tools, and large language models. Despite increasing computational sophistication, recurring barriers persisted, including uncertain target validity, diagnostic heterogeneity, limited external validation, poor transportability, interpretability challenges, workflow integration, equity, patient trust, and governance. Across eras, technical progress was cyclical rather than linear, with successive waves reproducing unresolved clinical and implementation challenges. Conclusions:The clinical impact of psychiatric AI will likely depend less on algorithmic novelty alone than on clearer clinical targets, prospective validation, implementation trials, patient-centered evaluation, equity-sensitive generalizability, and mental health-specific governance. Relevance to Clinical Practice:For routine psychiatric care, AI tools require evidence of clinical validity, transportability, workflow compatibility, patient acceptability, equity, and appropriate governance rather than technical performance alone.
Objective:Increases in the proportion of pediatric emergency department (ED) visits due to mental illness (MI) or intentional self-harm (ISH) in early months of the COVID-19 pandemic have been documented. Less is known about hospitalizations, or trends during later months of the pandemic. This study assessed changes in MI/ISH-related ED visits and hospitalizations among enrollees in Alabama's Children's Health Insurance Program, ALL Kids, during the pandemic. Methods:Administrative claims data from ALL Kids, were used for enrollees aged 6-17 from 2017 to 2022. The study-period was divided into pre-COVID (January 2017-March 2020), early COVID (April 2020-May 2021), and late COVID (June 2021-December 2022). Multivariate logistic regressions were employed to estimate the probabilities that ED visits and hospitalizations were MI/ISH related. Results:The study sample included 72,870 ED visits and 8205 hospitalizations for all causes. After adjusting for covariates, the proportion of MI/ISH-related ED visits increased from 2.5% pre-COVID to 4.1% in early COVID (p < 0.01), then declined to 2.8% in late COVID. MI/ISH-related hospitalizations rose from 26.3% pre-COVID to 31.3% in early COVID and remained elevated at 30.2% in late COVID. Increases were more pronounced among females and older enrollees. Conclusions:The COVID-19 pandemic was associated with increased MI/ISH-related ED visits and hospitalizations among publicly-insured youth, with hospitalizations remaining elevated later into the pandemic. Shifts in healthcare-seeking behaviors or admission criteria during the pandemic may have impacted these findings. Relevance to Clinical Practice:Findings on pediatric mental health during the COVID-19 pandemic can inform efficient health resources allocation for future public health crises. Our findings highlight the need for ensuring adequate access to health care for youth with severe mental health conditions during public health emergencies.
We describe a young woman with a compulsive drive to gain weight, characterized by fear of weight loss, distorted body image, and deliberate use of weight-inducing strategies.Her presentation reflects a pathological internalization of culturally valued corpulence, exceeding socially accepted behaviors and associated with psychological distress.This case may represent a probable culture-specific disorder and a psychocultural inversion of anorexia nervosa, highlighting the need for culturally informed diagnostic frameworks.